Literature DB >> 20025940

Modulation of PLAGL2 transactivation by positive cofactor 2 (PC2), a component of the ARC/Mediator complex.

Sara J Wezensky1, Tracey S Hanks, Michelle J Wilkison, Mary Cloud Ammons, Daniel W Siemsen, Katherine A Gauss.   

Abstract

The pleomorphic adenoma gene (PLAG) family of transcription factors regulates a wide range of physiological processes, including cell proliferation, tissue-specific gene regulation, and embryonic development, although little is known regarding the mechanisms that regulate PLAG protein activity. In this study, a yeast two-hybrid screen identified PC2, a component of the Mediator complex, as a PLAGL2-binding protein. We show that PC2 cooperates with PLAGL2 and PU.1 to enhance the activity of a known PLAGL2 target promoter (NCF2). The PLAGL2-binding element in the NCF2 promoter consisted of the core sequence of the bipartite PLAG1 consensus site, but lacked the G-cluster motif, and was recognized by PLAGL2 zinc fingers 5 and 6. Promoter and PLAGL2 mutants showed that PLAGL2 and PU.1 were required to bind to their respective sites in the promoter, and PC2 knockdown demonstrated that PC2 was essential for enhanced promoter activity. Co-immunoprecipitation and promoter-reporter studies reveal that the effect of PC2 on PLAGL2 target promoter activity was conferred via the C-terminus of PLAGL2, the region that is required for PC2 binding and contains the PLAGL2 activation domain. Importantly, chromatin immunoprecipitation analysis and PC2 knockdown studies confirmed that endogenous PC2 protein associated with the NCF2 promoter in MM1 cells in the region occupied by PLAGL2, and was required for PLAGL2 target promoter activity in TNF-alpha-treated MM1 cells, respectively. Lastly, the expression of another known PLAGL2 target gene, insulin-like growth factor II (IGF-II), was greatly diminished in the presence of PC2 siRNA. Together, the data identify PC2 as a novel PLAGL2-binding protein and important mediator of PLAGL2 transactivation. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20025940      PMCID: PMC2815083          DOI: 10.1016/j.gene.2009.12.003

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  35 in total

1.  AP-1 is essential for p67(phox) promoter activity.

Authors:  Katherine A Gauss; Peggy L Bunger; Mark T Quinn
Journal:  J Leukoc Biol       Date:  2002-01       Impact factor: 4.962

2.  Transcriptional regulation of the p67phox gene: role of AP-1 in concert with myeloid-specific transcription factors.

Authors:  S L Li; A J Valente; L Wang; M J Gamez; R A Clark
Journal:  J Biol Chem       Date:  2001-08-01       Impact factor: 5.157

3.  PLAG1, the main translocation target in pleomorphic adenoma of the salivary glands, is a positive regulator of IGF-II.

Authors:  M L Voz; N S Agten; W J Van de Ven; K Kas
Journal:  Cancer Res       Date:  2000-01-01       Impact factor: 12.701

4.  The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities.

Authors:  Karen Hensen; Isabelle C C Van Valckenborgh; Koen Kas; Wim J M Van de Ven; Marianne L Voz
Journal:  Cancer Res       Date:  2002-03-01       Impact factor: 12.701

5.  Identification of a karyopherin alpha 2 recognition site in PLAG1, which functions as a nuclear localization signal.

Authors:  Caroline V Braem; Koen Kas; Eva Meyen; Maria Debiec-Rychter; Wim J M Van De Ven; Marianne L Voz
Journal:  J Biol Chem       Date:  2002-03-06       Impact factor: 5.157

6.  PLAG1 fusion oncogenes in lipoblastoma.

Authors:  M K Hibbard; H P Kozakewich; P Dal Cin; R Sciot; X Tan; S Xiao; J A Fletcher
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

7.  Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11.

Authors:  Sean F Landrette; Ya-Huei Kuo; Karen Hensen; Sahar Barjesteh van Waalwijk van Doorn-Khosrovani; Paola N Perrat; Wim J M Van de Ven; Ruud Delwel; Lucio H Castilla
Journal:  Blood       Date:  2004-12-07       Impact factor: 22.113

8.  A zinc-finger protein, PLAGL2, induces the expression of a proapoptotic protein Nip3, leading to cellular apoptosis.

Authors:  Atsushi Mizutani; Takako Furukawa; Yasushi Adachi; Susumu Ikehara; Shigeru Taketani
Journal:  J Biol Chem       Date:  2002-02-06       Impact factor: 5.157

9.  A component of the ARC/Mediator complex required for TGF beta/Nodal signalling.

Authors:  Yoichi Kato; Raymond Habas; Yu Katsuyama; Anders M Näär; Xi He
Journal:  Nature       Date:  2002-07-24       Impact factor: 49.962

10.  On the epigenetic regulation of the human reelin promoter.

Authors:  Ying Chen; Rajiv P Sharma; Robert H Costa; Erminio Costa; Dennis R Grayson
Journal:  Nucleic Acids Res       Date:  2002-07-01       Impact factor: 16.971

View more
  4 in total

1.  Tyr99 phosphorylation determines the regulatory milieu of tumor suppressor p73.

Authors:  Y K Satija; S Das
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

2.  The role of pleomorphic adenoma gene-like 2 in gastrointestinal cancer development, progression, and prognosis.

Authors:  Bo Liu; Chong Lu; Yong-Xi Song; Peng Gao; Jing-Xu Sun; Xiao-Wan Chen; Mei-Xian Wang; Yu-Lan Dong; Hui-Mian Xu; Zhen-Ning Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

3.  DNA-methylation-mediated silencing of miR-486-5p promotes colorectal cancer proliferation and migration through activation of PLAGL2/IGF2/β-catenin signal pathways.

Authors:  Xiangxiang Liu; Xiaoxiang Chen; Kaixuan Zeng; Mu Xu; Bangshun He; Yuqin Pan; Huiling Sun; Bei Pan; Xueni Xu; Tao Xu; Xiuxiu Hu; Shukui Wang
Journal:  Cell Death Dis       Date:  2018-10-10       Impact factor: 8.469

4.  The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression.

Authors:  Zhenze Zhao; Spencer D Shelton; Alejandro Oviedo; Amy L Baker; Collin P Bryant; Soroush Omidvarnia; Liqin Du
Journal:  J Exp Clin Cancer Res       Date:  2020-02-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.